Filgrastim Terminated Phase 3 Trials for Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00005834S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma